Beijing: On July 25, China gave conditional approval to domestic firm Genuine Biotech’s Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus. The Azvudine tablet, which China approved in July last year to treat certain HIV-1 virus infections, has been given a conditional green light to treat adult patients with “normal type” COVID, the National Medical Products Administration said in a statement.
You May Also Like
Jawad Ahmed addresses suicide hike in youth
Jawad Ahmed, a well-known singer and founder of the Barabari Party Pakistan…
- Alina Hashmi
- September 17, 2021
COVID leads to brain damage in babies, in utero: Research
Researchers at the University of Miami reported on Thursday what they believe…
- Hafsa Mustafa
- April 7, 2023
Delta variant reaching alarming extent
In Karachi, the number of coronavirus delta variant infected patients has reached…
- Sanniah Hassan
- July 20, 2021
Coronavirus Survives on Surfaces for 28 Days: Study
ANKARA, Oct 12 (AA/APP): The novel coronavirus survives on surfaces for 28…
- Sanniah Hassan
- October 12, 2020